By combining immune monitoring on multiple platforms in a single center, the Human Immune Monitoring Center (HIMC) has created an ideal environment for standardization, technology development, and data mining related to immune monitoring. Over the last few year's, we have built an array of high-throughput and high-content assays that are proving useful for a variety of immunological studies. The Scientific Core B will provide standardized immunological assays across studies within this proposed U19 project, focusing especially on the characterization of key populations of blood leukocytes, particularly B cells, T cells, and basophils, in patients with peanut allergy (PA) as they undergo treatment with oral immunotherapy (OIT) or placebo, as well as work with individual projects to develop additional novel immune monitoring assays.
The specific aims are: 1. To provide standardized immune monitoring assays across projects. These will include detailed immunophenotyping of whole blood by mass cytometry (CyTOF), as well as phosphoepitope flow cytometry. By using the same standardized assays across all cohorts, we will greatly increase the power to test hypotheses related to any of the readouts of these assays. 2. To develop novel immune monitoring assays with individual projects. We will work with Project 3 on applications of MHC class ll-peptide multimer assays. These will be used in conjunction with microfluidic qPCR arrays, for comprehensive assessment of individual epitope-specific T cells. We will also develop phosphoepitope flow cytometry panels on the CyTOF mass cytometry platform. Once optimized, these technologies will be made available to other projects to create larger standardized data sets. 3. To facilitate mining of immune monitoring data. We will continue to expand our data integration and mining tool, Stanford Data Miner (SDM), for use with standard assays generated in this U19. We can also use SDM to compare U19 data with data generated with the same standardized assays in unrelated projects. We will work with the Data Management and Analysis Core A to mine those data using bioinformatics tools.

Public Health Relevance

The changes in the human immune system associated with peanut allergy (PA), or with its successful treatment, are not fully understood. We will use innovative standardized assays and data repository and analysis tools, and develop new ones, to discover new biomarkers of PA and to define changes in such biomarkers that may be indicative of the development of immune tolerance to peanut allergens.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI104209-05
Application #
9208122
Study Section
Special Emphasis Panel (ZAI1-PA-I)
Project Start
Project End
Budget Start
2017-02-01
Budget End
2018-01-31
Support Year
5
Fiscal Year
2017
Total Cost
$388,245
Indirect Cost
$140,955
Name
Stanford University
Department
Type
Domestic Higher Education
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94304
Andorf, Sandra; Borres, Magnus P; Block, Whitney et al. (2017) Association of Clinical Reactivity with Sensitization to Allergen Components in Multifood-Allergic Children. J Allergy Clin Immunol Pract 5:1325-1334.e4
Balbino, Bianca; Sibilano, Riccardo; Starkl, Philipp et al. (2017) Pathways of immediate hypothermia and leukocyte infiltration in an adjuvant-free mouse model of anaphylaxis. J Allergy Clin Immunol 139:584-596.e10
Galli, Stephen J; Starkl, Philipp; Marichal, Thomas et al. (2017) Mast Cells and IgE can Enhance Survival During Innate and Acquired Host Responses to Venoms. Trans Am Clin Climatol Assoc 128:193-221
Mukai, Kaori; Gaudenzio, Nicolas; Gupta, Sheena et al. (2017) Assessing basophil activation by using flow cytometry and mass cytometry in blood stored 24 hours before analysis. J Allergy Clin Immunol 139:889-899.e11
Boyd, Scott Dexter; Hoh, Ramona Amy; Nadeau, Kari Christine et al. (2017) Immune monitoring for precision medicine in allergy and asthma. Curr Opin Immunol 48:82-91
Andorf, Sandra; Manohar, Monali; Dominguez, Tina et al. (2017) Observational long-term follow-up study of rapid food oral immunotherapy with omalizumab. Allergy Asthma Clin Immunol 13:51
MacGinnitie, Andrew J; Rachid, Rima; Gragg, Hana et al. (2017) Omalizumab facilitates rapid oral desensitization for peanut allergy. J Allergy Clin Immunol 139:873-881.e8
Reber, Laurent L; Sibilano, Riccardo; Starkl, Philipp et al. (2017) Imaging protective mast cells in living mice during severe contact hypersensitivity. JCI Insight 2:
Reber, Laurent L; Gillis, Caitlin M; Starkl, Philipp et al. (2017) Neutrophil myeloperoxidase diminishes the toxic effects and mortality induced by lipopolysaccharide. J Exp Med 214:1249-1258
Sampath, Vanitha; Tupa, Dana; Graham, Michelle Toft et al. (2017) Deciphering the black box of food allergy mechanisms. Ann Allergy Asthma Immunol 118:21-27

Showing the most recent 10 out of 39 publications